Government extends the FDI screening regime as a response to the COVID-19 pandemics

On 29 April 2020, the French Government informed about an amendment to its foreign investment screening regime as a response to the COVID-19 pandemic. By decree of 27 April 2020, the list of sectors and critical technologies subject to review has been extended to include biotechnology.

• Type:

  • Entry and establishment (Approval and admission)

• Industry:

  • Services (Scientific research and development, Other professional, scientific and technical activities, Human health activities)

• Sources:

  • Legifrance, Arrêté du 27 avril 2020 relatif aux investissements étrangers en France, https://www.legifrance.gouv.fr/affichTexte.do;jsessionid=6C5C39D2CA0E9CBA2797A9F33D1A876D.tplgfr24s_1?cidTexte=JORFTEXT000041835304&dateTexte=&oldAction=rechJO&categorieLien=id&idJO=JORFCONT000041835077, 30 Apr 2020
  • https://www.tresor.economie.gouv.fr/, Covid-19 | Update of the foreign direct investment screening procedure in France, https://www.tresor.economie.gouv.fr/Articles/2020/04/30/covid-19-update-of-the-foreign-direct-investment-screening-procedure-in-france, 30 Apr 2020